Plaintiffs in a growing number of Tepezza lawsuits allege that hearing loss warnings should have been added before the drug was ever sold in the U.S.
A significant portion of users reported hearing loss, tinnitus, autophony and other hearing problems from Tepezza use.
The decision could determine whether 3M earplug lawsuit rulings made by a federal district judge can be challenged by the manufacturer in bankruptcy court.
Small group of attorneys will serve in leadership positions in the Tepezza MDL, taking certain actions that benefit all plaintiffs pursuing lawsuits over hearing loss or ringing in the ears from Tepezza infusions.
Plaintiff says if hearing had been tested before and after Tepezza infusions, she may have stopped using the drug in time to prevent permanent hearing loss
Judge Rodgers said the Court will continue to rule on Daubert and dispositive motions in the first wave of cases set to be remanded for trial while waiting for the results of the appeal.
Tepezza hearing damage lawsuits claim the manufacturer failed to warn patients and the medical community that the thyroid eye disease drug could cause hearing loss and tinnitus.
Aearo Technologies has appealed the earplug lawsuit bankruptcy dismissal, saying the litigation is too large and expensive to be resolved any other way.
The attorneys will take actions which will benefit all plaintiffs pursuing a Tepezza lawsuit over hearing loss and tinnitus.
The findings come after the FDA approved the sale of hearing aids over-the-counter late last year.
